Acidic pH derived from cancer cells may induce failed reprogramming of normal differentiated cells adjacent tumor cells and turn them into cancer cells

Medical Hypotheses

Volumn 83, Issue 6, 2014, Pages 668-672

  Tavakol, Shima ^a,b,c  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDITY; ARTICLE; CANCER CELL; CANCER GROWTH; CELL DIFFERENTIATION; DNA METHYLATION; DNA MODIFICATION; EPIGENETICS; HISTONE MODIFICATION; HUMAN; METASTASIS; NUCLEAR REPROGRAMMING; ONCOGENE C MYC; TUMOR DIFFERENTIATION; UPREGULATION; CELL TRANSFORMATION; EPISTASIS; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; METABOLISM; NEOPLASM; PATHOLOGY; PH; TUMOR CELL LINE;

HISTONE;

CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DNA METHYLATION; EPIGENESIS, GENETIC; EPISTASIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; HUMANS; HYDROGEN-ION CONCENTRATION; NEOPLASM METASTASIS; NEOPLASMS; UP-REGULATION;

EID: 84918782268     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2014.09.014     Document Type: Article

References (72)

1. Adikrisna R., Tanaka S., Muramatsu S., Aihara A., Ban D., Ochiai T., et al. Identification of pancreatic cancer stem cells and selective toxicity of chemotherapeutic agents. Gastroenterol 2012, 143(234-245):e237.
2. Zhang S., Balch C., Chan M.W., Lai H.-C., Matei D., Schilder J.M., et al. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 2008, 68:4311-4320.
3. Schatton T., Murphy G.F., Frank N.Y., Yamaura K., Waaga-Gasser A.M., Gasser M., et al. Identification of cells initiating human melanomas. Nature 2008, 451:345-349.
4. Marotta L.L.C., Polyak K. Cancer stem cells: a model in the making. Curr Opin Genet Dev 2009, 19:44-50.
5. Tafani M., Russo M. Reprogramming cancer stem cells. J Cancer Sci Ther 2012, 4:25-26.
6. Lu Y., Zhu H., Shan H., Lu J., Chang X., Li X., et al. Knockdown of Oct4 and Nanog expression inhibits the stemness of pancreatic cancer cells. Cancer Lett 2013, 340:113-123.
7. Wang X., Zhao Y., Xiao Z., Chen B., Wei Z., Wang B., et al. Alternative translation of OCT4 by an internal ribosome entry site and its novel function in stress response. Stem Cells 2009, 27:1265-1275.
8. Ben-Porath I., Thomson M.W., Carey V.J., Ge R., Bell G.W., Regev A., et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 2008, 40:499-507.
9. Feske S. Calcium signalling in lymphocyte activation and disease. Nat Rev Immunol 2007, 7:690-702.
10. Jeter C.R., Liu B., Liu X., Chen X., Liu C., Calhoun-Davis T., et al. NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene 2011, 30:3833-3845.
11. Mak V., Siu M., Wong O., Chan K., Ngan H., Cheung A. Dysregulated stemness-related genes in gynecological malignancies. Histol Histopathol 2012, 27:1121-1130.
12. Chiou S.-H., Wang M.-L., Chou Y.-T., Chen C.-J., Hong C.-F., Hsieh W.-J., et al. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res 2010, 70:10433-10444.
13. Wong D.J., Liu H., Ridky T.W., Cassarino D., Segal E., Chang H.Y. Module map of stem cell genes guides creation of epithelial cancer stem cells. Cell Stem Cell 2008, 2:333-344.
14. Sánchez-García I., Vicente-Dueñas C., Cobaleda C. The theoretical basis of cancer-stem-cell-based therapeutics of cancer: can it be put into practice?. BioEssays 2007, 29:1269-1280.
15. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
16. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
17. Yamanaka S. Induced pluripotent stem cells: past, present, and future. Cell Stem Cell 2012, 10:678-684.
18. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
19. Maherali N., Sridharan R., Xie W., Utikal J., Eminli S., Arnold K., et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 2007, 1:55-70.
20. Woltjen K., Michael I.P., Mohseni P., Desai R., Mileikovsky M., Hämäläinen R., et al. PiggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009, 458:766-770.
21. Wernig M., Meissner A., Foreman R., Brambrink T., Ku M., Hochedlinger K., et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007, 448:318-324.
22. Loewer S., Cabili M.N., Guttman M., Loh Y.-H., Thomas K., Park I.H., et al. Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nat Genet 2010, 42:1113-1117.
23. Spike B.T., Wahl G.M. P53, stem cells, and reprogramming tumor suppression beyond guarding the genome. Genes Cancer 2011, 2:404-419.
24. Zhang X., Cruz F.D., Terry M., Remotti F., Matushansky I. Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming. Oncogene 2013, 32:2249-2260.
25. Nakagawa M., Takizawa N., Narita M., Ichisaka T., Yamanaka S. Promotion of direct reprogramming by transformation-deficient Myc. Proc Natl Acad Sci 2010, 107:14152-14157.
26. Maekawa M., Yamaguchi K., Nakamura T., Shibukawa R., Kodanaka I., Ichisaka T., et al. Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1. Nature 2011, 474:225-229.
27. Hiyama E., Hiyama K. Telomere and telomerase in stem cells. Br J Cancer 2007, 96:1020-1024.
28. Feinberg A.P., Tycko B. The history of cancer epigenetics. Nat Rev Cancer 2004, 4:143-153.
29. Jones P.A., Baylin S.B. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002, 3:415-428.
30. Jaenisch R., Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003, 33:245-254.
31. BenBaruch A. Inflammation-associated immune suppression in cancer: the roles played by cytokines chemokines and additional mediators. Seminars in cancer biology 2006, 38-52. Elsevier.
32. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
33. Ben-Neriah Y., Karin M. Inflammation meets cancer, with NF-(kappa) B as the matchmaker. Nat Immunol 2011, 12:715-723.
34. De Milito A., Canese R., Marino M.L., Borghi M., Iero M., Villa A., et al. PH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity. Int J Cancer 2010, 127:207-219.
35. Becelli R., Renzi G., Morello R., Altieri F. Intracellular and extracellular tumor pH measurement in a series of patients with oral cancer. J Craniofac Surg 2007, 18:1051-1054.
36. Coss R.A., Storck C.W., Daskalakis C., Berd D., Wahl M.L. Intracellular acidification abrogates the heat shock response and compromises survival of human melanoma cells 1. Mol Cancer Ther 2003, 2:383-388.
37. Hirpara J.L., Clément M.-V., Pervaiz S. Intracellular acidification triggered by mitochondrial-derived hydrogen peroxide is an effector mechanism for drug-induced apoptosis in tumor cells. J Biol Chem 2001, 276:514-521.
38. Hjelmeland A.B., Wu Q., Heddleston J., Choudhary G., MacSwords J., Lathia J., et al. Acidic stress promotes a glioma stem cell phenotype. Cell Death Differ 2011, 18:829-840.
39. Robey I.F., Baggett B.K., Kirkpatrick N.D., Roe D.J., Dosescu J., Sloane B.F., et al. Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Res 2009, 69:2260-2268.
40. Raghunand N., Gillies R.J. PH and drug resistance in tumors. Drug Resist Update 2000, 3:39-47.
41. Hu T., Liu S., Breiter D.R., Wang F., Tang Y., Sun S. Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis. Cancer Res 2008, 68:6533-6540.
42. Obokata H., Wakayama T., Sasai Y., Kojima K., Vacanti M.P., Niwa H., et al. Stimulus-triggered fate conversion of somatic cells into pluripotency. Nature 2014, 505:641-647.
43. Katara G., Jaiswal M., Kulshrestha A., Kolli B., Gilman-Sachs A., Beaman K. Tumor-associated vacuolar ATPase subunit promotes tumorigenic characteristics in macrophages. Oncogene 2013, 10.1038/onc.2013.532.
44. Marino M., Fais S., Djavaheri-Mergny M., Villa A., Meschini S., Lozupone F., et al. Proton pump inhibition induces autophagy as a survival mechanism following oxidative stress in human melanoma cells. Cell Death Dis 2010, 1:e87.
45. De Milito A., Iessi E., Logozzi M., Lozupone F., Spada M., Marino M.L., et al. Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species. Cancer Res 2007, 67:5408-5417.
46. Raghunand N., Mahoney B., van Sluis R., Baggett B., Gillies R.J. Acute metabolic alkalosis enhances response of C3H mouse mammary tumors to the weak base mitoxantrone. Neoplasia (New York, NY) 2001, 3:227.
47. Munoz-Pinedo C., El Mjiyad N., Ricci J. Cancer metabolism: current perspectives and future directions. Cell Death Dis 2012, 3:e248.
48. Polo J.M., Anderssen E., Walsh R.M., Schwarz B.A., Nefzger C.M., Lim S.M., et al. A molecular roadmap of reprogramming somatic cells into iPS cells. Cell 2012, 151:1617-1632.
49. Lin C.Y., Lovén J., Rahl P.B., Paranal R.M., Burge C.B., Bradner J.E., et al. Transcriptional amplification in tumor cells with elevated c-Myc. Cell 2012, 151:56-67.
50. Kim J., Chu J., Shen X., Wang J., Orkin S.H. An extended transcriptional network for pluripotency of embryonic stem cells. Cell 2008, 132:1049-1061.
51. Semi K., Matsuda Y., Ohnishi K., Yamada Y. Cellular reprogramming and cancer development. Int J Cancer 2013, 132:1240-1248.
52. Keith B., Simon M.C. Hypoxia-inducible factors, stem cells, and cancer. Cell 2007, 129:465-472.
53. Covello K.L., Kehler J., Yu H., Gordan J.D., Arsham A.M., Hu C.-J., et al. HIF-2α regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev 2006, 20:557-570.
54. Pollard P., Loenarz C., Mole D., McDonough M., Gleadle J., Schofield C., et al. Regulation of Jumonji-domain-containing histone demethylases by hypoxia-inducible factor (HIF)-1alpha. Biochem J 2008, 416:387-394.
55. Wellmann S., Bettkober M., Zelmer A., Seeger K., Faigle M., Eltzschig H.K., et al. Hypoxia upregulates the histone demethylase JMJD1A via HIF-1. Biochem Biophys Res Commun 2008, 372:892-897.
56. Krieg A.J., Rankin E.B., Chan D., Razorenova O., Fernandez S., Giaccia A.J. Regulation of the histone demethylase JMJD1A by hypoxia-inducible factor 1α enhances hypoxic gene expression and tumor growth. Mol Cell Biol 2010, 30:344-353.
57. Yang J., Ledaki I., Turley H., Gatter K.C., Montero J.C.M., Li J.L., et al. Role of hypoxia-inducible factors in epigenetic regulation via histone demethylases. Ann N Y Acad Sci 2009, 1177:185-197.
58. Sharma S., Kelly T.K., Jones P.A. Epigenetics in cancer. Carcinogenesis 2010, 31:27-36.
59. Esteller M. Epigenetics in cancer. N Engl J Med 2008, 358:1148-1159.
60. Bom A.P.D.A., Freitas M.S., Moreira F.S., Ferraz D., Sanches D., Gomes A.M., et al. The p53 core domain is a molten globule at low pH functional implications of a partially unfolded structure. J Biol Chem 2010, 285:2857-2866.
61. Echigoya Y., Morita S., Itou T., Sakai T. Effects of extracellular lactate on production of reactive oxygen species by equine polymorphonuclear leukocytes in vitro. Am J Vet Res 2012, 73:1290-1298.
62. He J., Xu Q., Jing Y., Agani F., Qian X., Carpenter R., et al. Reactive oxygen species regulate ERBB2 and ERBB3 expression via miR-199a/125b and DNA methylation. EMBO Rep 2012, 13:1116-1122.
63. Lim S.-O., Gu J.-M., Kim M.S., Kim H.-S., Park Y.N., Park C.K., et al. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. Gastroenterol 2008, 135(2128-2140):e2128.
64. Min J.Y., Lim S.-O., Jung G. Downregulation of catalase by reactive oxygen species via hypermethylation of CpG island II on the catalase promoter. FEBS Lett 2010, 584:2427-2432.
65. Rofstad E.K., Mathiesen B., Kindem K., Galappathi K. Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res 2006, 66:6699-6707.
66. Samouilov A., Efimova O.V., Bobko A.A., Sun Z., Petryakov S., Eubank T.D., et al. In vivo proton-electron double-resonance imaging of extracellular tumor pH using an advanced nitroxide probe. Anal Chem 2013, 86(2):1045-1052.
67. Ehrlich M. DNA methylation in cancer: too much, but also too little. Oncogene 2002, 21:5400-5413.
68. Hu T., Liu S., Breiter D., Wang F., Tang Y., Sun S. Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis. Klin Padiatr 2012, 224:A9.
69. Guo Y., Mantel C., Hromas R.A., Broxmeyer H.E. Oct-4 is critical for survival/antiapoptosis of murine embryonic stem cells subjected to stress: effects associated with Stat3/survivin. Stem Cells 2008, 26:30-34.
70. Chen T., Du J., Lu G. Cell growth arrest and apoptosis induced by Oct4 or Nanog knockdown in mouse embryonic stem cells: a possible role of Trp53. Mol Biol Rep 2012, 39:1855-1861.
71. Chen R.Z., Pettersson U., Beard C., Jackson-Grusby L., Jaenisch R. DNA hypomethylation leads to elevated mutation rates. Nature 1998, 395:89-93.
72. Eden A., Gaudet F., Waghmare A., Jaenisch R. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 2003, 300:455.